Why Will Americas Witness Widescale Use of Neem Extract in Future?

 The CDC states that there were 28.7 million diabetic patients in the U.S. in 2019. In addition, the International Diabetic Federation states that 30,987,900 adults were living with diabetes in the North America and Caribbean (NAC) region in 2020, and this number will rise to 63 million by 2045. Moreover, the WHO forecasts that nearly 11.3% of the Brazilian population will be diagnosed with diabetes by 2030.  

The growing prevalence of diabetes will, therefore, strengthen the Americas neem extract market in the foreseeable future, owing to the anti-diabetic activity of neem. Oral administration of dried neem is often recommended for diabetic patients as it helps reduce creatinine, glucose, lipids, cholesterol, urea, and triglycerides in mammals. Additionally, nimbidiol, extracted from barks and roots of neem trees, can control diabetes by inhibiting glucosidases. Moreover, prophylactic treatment with neem seed oil or leaf partially prevents the alloxan-induced surge in blood sugar.

Moreover, the surging need for biopesticides, on account of the soaring vehicle production, will also facilitate the consumption of neem extracts in the Americas. The United States Department of Agriculture (USDA) states that the U.S. yielded 739 million hundredweight (cwt) of vegetable and melon crops in 2019. Nearly 2.38 million acres of farmland were dedicated to the production of vegetables in the country. Neem extracts serve as non-neurotoxic pest control agents, which exhibit insecticidal effects, owing to which farmers are shifting toward neem-based pesticides.

In addition, the surging public concerns regarding harmful effects of chemical-based personal care products, such as face washes, face creams, shampoos, and bathing soaps, will accelerate the use of neem extracts in the Americas. To meet the changing needs of people, personal care product manufacturers are using seed extract, bark extract, and leaf extract in their offerings for the people of the U.S., Canada, Brazil, Haiti, Nicaragua, and the Dominican Republic. Moreover, neem extract-based products are used to treat acne, blackheads, and pigmentation.

According to P&S Intelligence, the Americas neem extract market is dominated by American Vanguard Corporation, Terramera Inc., Bayer AG, Certis USA LLC, Fortune Biotech Ltd., and Groupo Ultraquimia. In recent years, these companies have constantly focused on attracting more customers due to the entry of numerous small enterprises offering neem extracts. The increasing competition among neem extract-based product manufacturers can also be attributed to the low switching cost of buyers of the region.

Thus, the increasing incidence of diabetes, accelerating shift toward bio-based pesticides, and rising public concerns about the detrimental impact of chemical-based personal care products will propel the use of neem extracts in the Americas.